California Court of Appeal

Dismissal of plaintiffs' claims is affirmed in an action under Proposition 65 and the state unfair competition law against manufacturers of vaccines alleging that defendants exposed plaintiffs and consumers to substances known to cause cancer or reproductive toxicity without providing adequate warning.

Appellate Information

• Decided 11/28/2005
• Published 11/29/2005

Judges

• KITCHING, J.

Court

• California Court of Appeal

Counsel

• For Appellant:
  
• The Law Offices of Shawn Khorrami, Shawn Khorrami, Matt Bailey;  Waters & Kruas, C. Andrew Waters and Paul Cook, Los Angeles, for Plaintiffs and Appellants., Bill Lockyer, Attorney General, Tom Greene, Chief Assistant Attorney General, Theodora Berger, Assistant Attorney General, Edward G. Weil and Susan S. Fiering, Deputy Attorneys General, for Bill Lockyer, Attorney General of the State of California, as Amicus Curiae on behalf of Plaintiffs and Appellants.


• For Appellees:
  
• Reed Smith, James M. Wood, Oakland, Raymond Cardozo;  Shook, Hardy & Bacon, Andrew See and Sharon M. Williams for Defendant and Respondent Eli Lilly and Company., Squire, Sanders & Dempsey, Eduardo Roy, Kevin T. Haroff and Denise A. Smith, San Francisco, for Defendant and Respondent McKesson Medical-Surgical, Inc., Lewis Brisbois Bisgaard & Smith, George E. Nowotny, Kevin Eng, Los Angeles, and Lisa Willhelm Cooney, San Diego, for Defendant and Respondent Priority Health Care Corporation., Gordon & Rees, Stuart M. Gordon, James R. Reilly, Fletcher C. Alford, San Francisco;  Reed Smith, Timothy B. Bradford, Marilyn A. Moberg, Los Angeles, Raymond M. Williams;  Orrick Herrington & Sutcliffe, Daniel J. Thomasch, Richard W. Mark, and Lauren J. Elliot for Defendant and Respondent Wyeth., Fulbright & Jaworski, Jeffery B. Margulies and Spencer Persson for Defendant and Respondent SmithKline Beecham Corporation etc., Bingham McCutchen, Trenton H. Norris and Peter M. Morrisette, San Francisco, for Defendants and Respondents King Pharmaceuticals and Parkedale Pharmaceuticals., Morris Polich & Purdy and Janet Richardson, Los Angeles, for Defendant and Respondent Abbott Laboratories., Sedgwick, Detert, Moran & Arnold, Ralph Campillo, Douglas J. Collodel, Wendy Tucker, Los Angeles, and Kurt F. Zimmerman for Defendant and Respondent Merck & Co., Inc., Reed Smith, Gary A. Jeffrey, Oakland;  Butler, Snow, O'Mara, Stevens & Cannada and Lee Davis Thames for Defendant and Respondent Baxter Healthcare Corporation., Breidenbach, Huchting & Hamblet, Thomas C. Corless, Los Angeles, and Debby Dorny for Defendant and Respondent Bergen Brunswig Corporation., Herzfeld & Rubin, Michael Zuk, Los Angeles, and John Loomis for Defendants and Respondents Aventis Pasteur Inc., Shaw, Terhar & Lamontagne, Matthew A. Schumacher and John W. Shaw, Los Angeles, for Defendant and Respondent Celltech Pharmaceuticals, Inc., Bayuk & Associates, Inc. and Christopher Bayuk, San Diego, for Defendant and Respondent Spectrum Laboratory Products, Inc., Kirkpatrick & Lockhart and Frederick J. Ufkes for Defendant and Respondent Sigma-Aldrich Corp., Covington & Burling, Steven J. Rosenbaum, Kelly A. Falconer and Richard A. Jones, San Francisco, for Pharmaceutical Research and Manufacturers of America as Amicus Curiae on behalf of Defendants and Respondents.